Gowtham Grandhi

Excited to share our inaugural paper from the DILWALE South Asian CV Health Registry established by @AAgarwalaMD 🔗#undfig1" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl… -31K adults (largest 🇺🇸 cohort) -⬆️ RF burden: HTN,DM -RFs highest in 🚹 & premature CVD -HTN & HLD a/w 3.5x CVD risk -🚺under Rx w LLT

Challenges in the Cardiovascular Evaluation and Management of Patients With Obesity ⁦@SeanPGaine⁩ ⭐️ #cvPrev ⁦@rblument1⁩@gowthyharsha⁩ ⁦@MichaelJBlaha⁩ ⁦@AAgarwalaMD⁩ ⁦@EugeniaGianos⁩ ⁦@DrEugeneYang⁩ acc.org/latest-in-card…

We're pleased to announce Dr. Harlan M. Krumholz, a globally esteemed cardiologist and researcher, as the incoming editor-in-chief of #JACC! Join us in celebrating his appointment and learn more about his incredible contributions to the field: bit.ly/3Te9XfF @hmkyale

It is time again to recruit for our Cardiometabolic Fellowship in the Johns Hopkins Ciccarone Center. This is dedicated for those with SPECIFIC interest in preventive cardiology and cardiometabolic disease. If interested, please DM me and I will ask for your CV and PS.

FH pts, no clinical CAD, mean age 48 y; treated median 11 years, LDL-C 155 mg/dL. 42% CAC=0 & 33% no plaque in CTA, varying by age and sex. We Should use more imaging in FH to improve risk stratification @FHFamiliar @HFIberoamerica @society_eas doi.org/10.1016/j.ajpc…

PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): prospective study protocol investigating prevalence, severity & determinants of atherosclerotic CVD in the young adult Pakistani pop… @BMJ_Open bmjopen.bmj.com/content/13/11/…

Great to see @VCUHealthHeart past and present at #AHA2023, especially boss of the bosses @AbbateAntonio 🫶🏼 @TheRhythmDoc @mitchbk1 @kalahasty @gowthyharsha @Schatz_Aa @AjayPMD @VCUHealth

Celebrating #Diwali at #AHA23 with great friends and good Indian food #vegthali #masaladosa Thanks @Shanjeev96 for the restaurant suggestion! We missed you guys @AAgarwalaMD @AnumSaeedMD @jaideeppatelmd

@DrMarthaGulati @gcfmd @AndrewJSauer @robmentz @dranulala @ShelleyZieroth @mmamas1973 @heartofthemater @JeffTeuteberg @noshreza Those are some staggering NNTs!

Many thanks to our incredible co-authors! @BudoffMd @seamuswhelton @alanrozanskimd @mdmiedema @DrRumberger @lesleejshaw @gowthyharsha @ZeinaDardari @RishavRAdhikari @gpsoroosh @kunaljhamd @OmarDzaye @ErfanTasdighi @JohnErhabor @Sant_J_Kumar, and Dr Berman.

🚨 📌CVD risk-stratification among persons w/ obesity is key esp in this era of expanded obesity pharmacotherapy 📌CAC may help identify optimal candidates for novel but costly anti-obesity medications @MichaelJBlaha @MichaelAlbertMD @rblument1 @khurramn1 onlinelibrary.wiley.com/doi/10.1002/ob…

@DrMarthaGulati @amehta_09 @marurinella @ASPCardio @PamTaubMD @rblument1 @HEP_Journal @amehta_09 crystal clear as always. Thanks for the great talk!

CAC-PREVENTABLE is an exciting ancillary trial exploring the utility of coronary artery calcification (CAC) as a predictor for benefit of statin 💊 therapy in PREVENTABLE. 👏 Great talk by Dr. Melissa Daubert 👏

Amazing dinner with amazing #CVPrev friends #ASPC2023 @DBelardoMD @MichaelJBlaha

Status of #cvPrev training in the 🇺🇸—- not much 🤷🏻‍♀️ Excellent perspective and thought provoking questions by Dr. Maron….we have work to do! @ASPCardio #ASPC2023

Special thank you to @emoryheart mentors Drs @amehta_09 , Sperling, Quyyumi and the entire team @vardhmaan_jain @gowthyharsha @nidhipat19 @Zakaria34a

Does Elevated High-Density Lipoprotein #HDL Cholesterol Protect Against Cardiovascular Disease? #cvprev Led by 🌟FIT @AlexRazavi academic.oup.com/jcem/advance-a…

@hmkyale @CesarCaraballoC @YaleMed @YaleIMed @MarkDSiegel1 Congratulations, Cesar 👏🏼👏🏼👏🏼

So proud of @CesarCaraballoC, newly matched to @YaleMed @YaleIMed. After several years of spectacular research work at CORE, this kind, brilliant, collaborative, compassionate, remarkable person, who makes all of us better people, will begin his next chapter. @MarkDSiegel1

Congratulations, Rishav 👏🏼👏🏼

Congratulations, Ellen!